Login

Dr. Vishal Swaminathan - Residency at Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Residents describe their training experience at Mayo Clinic's Department of Ophthalmology.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Career Growth and Supportive Environment at Kip Santo
00:10:00
Chesapeake Gold's Matatus Project: Advancing a World-Class Gold-Silver Deposit with Strategic Development
00:00:00
Nancy L. Keating, MD, MPH Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School | Cancer Research From Diagnosis to End of Life
00:10:00
Key Insights from Arise's CEO and CFO Interview| Per-Erik Eriksson , CEO, Arise AB.
00:10:00
We believe in backing our portfolio company founders all the way from idea|Fady Yacoub,Managing Director, HOF Capital
00:10:00
Commvault CEO Sanjay Mirchandani discusses the company's earnings in a Fortt Knox segment.|Sanjay Mirchandani, has served as our President and Chief Executive Officer of Commvault
00:10:00
Crafting Your Financial Future | Smith Bruer Advisors
00:10:00
Focuses on early stage investments in technology companies|Ann Miura-Ko,Co-Founding Partner,Floodgate
00:10:00
Talon Metals Reports High-Grade Nickel and Copper Intercept in Raptor Zone
00:10:00
"Insights into Lodging Sector Recovery and Portfolio Expansion: Interview with Richard from More Hotels and Resorts"|CEO ,Braemar Hotels & Resorts Inc
00:10:00
Growth and Strategy Overview of Minerros, a Colombian Gold Producer
00:10:00
spectrum of technical backgrounds and the versatility to invest at any stage|Deena Shakir,Partner,Lux Capital

© 2017 - Neuhu+